JANX Stock Price - Janux Therapeutics, Inc. logo

JANX Stock Price

Janux Therapeutics, Inc.

$10.08
-$0.21(-2.04%)
39
Overall
60
Value
9
Tech
50
Quality
How is this score calculated?
Market Cap
$616.73M
Volume
1.11M
52W Range
$11.16 - $35.34
Target Price
$31.87

JANX stock price is $10.08 (-2.04% on the day), giving Janux Therapeutics, Inc. a market cap of $616.73M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

JANX Stock Overview

Price
$10.08
Previous close
$10.29
Open
$10.11
Market cap
$616.73M
52-week range
$11.15 - $35.34
1-year price target
$31.87
Sector
Healthcare
Industry
Biotechnology
Exchange
Nasdaq
MarketXLS Rank
39

About Janux Therapeutics, Inc.

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients with cancer. Its clinical candidates include JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor or EGFR-TRACTr that is in Phase 1 clinical trial for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma, and triple-negative breast cancer. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

ABCD
1SymbolPriceChangeVol
2JANX$10.08-2.0%1.11M
3
4
5
6

Get Janux Therapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.